Rare diseases
Investigational molecules
Locations
Back to Germany1 286 clinical trials in Aachen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis
GermanyStudy on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant
GermanyStudy on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds
GermanyStudy on Elinzanetant for Treating Sleep Disturbances in Menopausal Women
GermanyStudy Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
GermanyStudy to Identify Unknown Primary Cancer Using [18F]-AlF-FAPI-74 PET-CT for Patients with Carcinoma of Unknown Primary
The NetherlandsStudy of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy
GermanyStudy Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases
GermanyStudy on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction
GermanyStudy on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment
BelgiumStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
GermanyStudy of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma treatments and various forms of breast cancer therapies, including studies of novel immunotherapy combinations for head and neck cancers.
Advanced therapeutic approaches including targeted treatments and combination therapies are being evaluated for improved patient outcomes.
Research targeting heart failure prevention and management of cardiovascular complications, with emphasis on innovative drug combinations and preventive treatments.
Studies focus on reducing cardiovascular events and improving long-term patient outcomes.
Clinical investigations addressing various chronic conditions, including inflammatory diseases and dermatological disorders.
Evaluating new therapeutic approaches for managing long-term conditions and improving quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
